Evidence map›Paper›PMID 37671264›Full record

ArticleCurrent developments in nutrition2023

Lysophosphatidylcholine-Rich Nutrition Therapy Increased Gut Absorption of Coingested Dietary Fat: a Randomized Controlled Trial.

Alyssa Tindall, Maria Mascarenhas, Asim Maqbool, Virginia A Stallings

Erratum issued Registry-linked trialOpen access · goldAbstract readCase Reports
In one paragraph

Article in Current developments in nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07554560 (Feasibility, Tolerance, and Fat Metabolism Pilot Study of a Structured Lipid Medical Food in Patients With Pancreatic Cancer), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07554560 narecruitingnot on this mapstarted 2026, after this paper: background citation

Feasibility, Tolerance, and Fat Metabolism Pilot Study of a Structured Lipid Medical Food in Patients With Pancreatic Cancer

TypeinterventionalSponsorChildren's Hospital of PhiladelphiaRan2026 to 2027Enrolled18ConditionsPancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Neuroendocrine Tumor (NET)ArmsStructured Lipid Medical Food
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alyssa TindallDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, PA, United States.
Maria MascarenhasDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, PA, United States.
Asim MaqboolDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, PA, United States.
Virginia A StallingsDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, PA, United States.
Children's Hospital of Philadelphia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unintentional weight loss is common in persons with chronic and acute disease and is often caused by insufficient intake or malabsorption. A new lysophosphatidylcholine (LPC)-rich structured lipid powder has micelle-like activity that facilitates digestion and absorption, independent of lipase and bile acids. The aim of this secondary analysis was to determine if recycled LPC increased fat absorption of coingested food. Fasting plasma fatty acid (FA) concentrations were measured at baseline and 3 mo in children (

Indexed as

cystic fibrosisenteral nutritionfat absorptionfatty acidslipidsmalnutrition

Identifiers

PMID37671264
PMCPMC10475471
OpenAlexW4385431565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.